ArticleFrontiers in immunology2025
Burden of immune-related skin diseases worldwide, 1991-2021: insights and prediction from the Global Burden of Disease Study.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The associations between residential environment and atopic dermatitis of adults: a prospective cohort study.BMC public health · 2026Article
- Epigenetic Therapies for Inflammatory and Immune-Mediated Skin Diseases.Biomedicines · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Immune-mediated dermatological conditions, including dermatitis, urticaria, alopecia areata, and psoriasis, are common skin diseases that contribute to substantial health loss, economic burden, and pain across individuals of all ages worldwide. Methods: Using data from the Global Burden of Disease (GBD) 2021 study, we analyzed age-standardized incidence, prevalence rate, and disability-adjusted life years (DALYs) for global main four immune-related skin diseases-including dermatitis (atopic, contact, and seborrheic), urticaria, alopecia areata, and psoriasis from 1991 to 2021, with corresponding 95% uncertainty intervals (UIs), stratified by sex, age, geographical location, and sociodemographic index (SDI). We further projected incidence through 2035 using a Holt-damped model incorporating trend components but excluding seasonality. Results: Dermatitis had the highest estimated age-standardized prevalence rate (ASPR: 5459.07 per 100,000; 95% UI: 5064.87-5875.73), followed by psoriasis (354.07; 95% UI: 342.42-364.08), urticaria (1094.59; 95% UI: 969.18-1240.42), and alopecia areata (42.89; 95% UI: 41.74-44.14). Immune-related dermatoses consistently showed higher age-standardized rates in females than males. The estimated annual percentage change (EAPC) revealed distinct temporal patterns: dermatitis (-0.155) and alopecia areata (-0.127) showed slight declines, whereas psoriasis exhibited an upward trend (0.24), and urticaria remained stable with a modest increase (0.01). Age distribution: Dermatitis/urticaria peaked in children, alopecia areata in adulthood, and psoriasis in middle age. Conclusions: Immune-related skin diseases-including dermatitis, urticaria, alopecia areata, and psoriasis-are highly prevalent worldwide, with notable variations by age, sex, and region. Females are disproportionately affected. These trends underscore the need for targeted, sex- and region-specific public health interventions to optimize the allocation of healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.